.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The CLASSIC randomized trial was an important step in defining the role of laparoscopic-assisted surgery for colorectal cancer. The study compared laparoscopic-assisted surgery with conventional open surgery and evaluated short-term surgical outcomes as well as longer-term cancer outcomes. Although laparoscopic procedures can be technically demanding, the trial showed that appropriately performed minimally invasive colorectal surgery could achieve acceptable oncological results while offering the familiar recovery advantages of a less invasive approach. The significance of CLASSIC lies in its contribution to the transition from proof-of-concept laparoscopy to routine colorectal practice. It helped demonstrate that conversion to open surgery, postoperative morbidity, recurrence and survival could be assessed within a rigorous randomized framework rather than relying solely on single-centre experience. The trial also emphasized the importance of surgeon training and patient selection as minimally invasive surgery expanded. For today's surgeon, CLASSIC is best viewed as one of the foundational trials supporting laparoscopic colorectal surgery. Its results helped establish that the question is not simply whether laparoscopy is feasible, but whether it can reproduce sound oncological surgery with acceptable perioperative outcomes. Modern enhanced-recovery pathways and better technology have since further strengthened the practical value of minimally invasive colorectal surgery.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The CLASSIC randomized trial was an important step in defining the role of laparoscopic-assisted surgery for colorectal cancer. The study compared laparoscopic-assisted surgery with conventional open surgery and evaluated short-term surgical outcomes as well as longer-term cancer outcomes. Although laparoscopic procedures can be technically demanding, the trial showed that appropriately performed minimally invasive colorectal surgery could achieve acceptable oncological results while offering the familiar recovery advantages of a less invasive approach. The significance of CLASSIC lies in its contribution to the transition from proof-of-concept laparoscopy to routine colorectal practice. It helped demonstrate that conversion to open surgery, postoperative morbidity, recurrence and survival could be assessed within a rigorous randomized framework rather than relying solely on single-centre experience. The trial also emphasized the importance of surgeon training and patient selection as minimally invasive surgery expanded. For today's surgeon, CLASSIC is best viewed as one of the foundational trials supporting laparoscopic colorectal surgery. Its results helped establish that the question is not simply whether laparoscopy is feasible, but whether it can reproduce sound oncological surgery with acceptable perioperative outcomes. Modern enhanced-recovery pathways and better technology have since further strengthened the practical value of minimally invasive colorectal surgery.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
